{"mainPropery":{"diseaseId":10902,"diseaseName":"Neuroacanthocytosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10902/neuroacanthocytosis","synonyms":["Neuroacanthocytosis syndrome"],"synonyms-with-source":[{"name":"Neuroacanthocytosis syndrome"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"263440"}]},"diseaseCategories":[],"organizations":[{"resourceID":516,"resourceName":"Advocacy for Neuroacanthocytosis Patients","abbreviation":"","address1":"32 Launceston Place","address2":"London W8 5RN","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"England","phone":"+44 (0) 20 7937 2938","tty":"","tollFree":"","fax":"","email":"ginger@naadvocacy.org","url":"http://www.naadvocacy.org/","freeText":""},{"resourceID":713,"resourceName":"Mental Health America","abbreviation":"MHA","address1":"500 Montgomery Street","address2":"Suite 820","address3":"","address4":"","address5":"","city":"Alexandria","state":"VA","zip":"22314","country":"United States","phone":"+1-703-684-7722 ","tty":"","tollFree":"1-800-969-6642","fax":"+1-703-684-5968","email":"https://www.mhanational.org/get-involved/contact-us","url":"https://www.mhanational.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=neuroacanthocytosis' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Neuroacanthocytosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?term=neuroacanthocytosis' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Neuroacanthocytosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/neuroacanthocytosis' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/975/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/neuroacanthocytosis/neuroacanthocytosis.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1152923-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=263440' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:200150' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":5803,"questionText":"What is neuroacanthocytosis?","answerText":"<strong>Neuroacanthocytosis (NA)</strong> refers to a group of genetic&nbsp;disorders that are characterized by misshapen, spiny red blood cells (acanthocytosis) and neurological abnormalities, especially movement disorders.[4798] The onset, severity and specific physical findings vary depending upon the specific type of&nbsp;NA present.[4798]&nbsp;Signs and symptoms usually include <a href=\"http://www.ninds.nih.gov/disorders/chorea/chorea.htm\" target=_blank>chorea</a> (involuntary, dance-like movements), involuntary movements of the face and tongue, progressive cognitive impairment, muscle weakness, seizures and behavioral or personality changes.[4798][4799] NA syndromes&nbsp;typically progress to cause serious, disabling complications and are usually fatal.[4798] NA is inherited, but the disease-causing&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=_blank>gene</a> and <a href=\"http://ghr.nlm.nih.gov/handbook/inheritance/inheritancepatterns\" target=_blank>inheritance pattern</a> varies for each type.[4798][4799] Although there is some disagreement in the medical literature about what disorders should be classified as forms of NA, four distinct disorders are usually classified as the \"core\"&nbsp;NA syndromes - <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/3956/Choreaacanthocytosis.aspx\" target=_blank>chorea-acanthocytosis</a>, <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10731/McLeod_syndrome.aspx\" target=_blank>McLeod syndrome</a>, <a href=\"http://ghr.nlm.nih.gov/condition/huntington-disease-like-syndrome\" target=_blank>Huntington's disease-like 2</a> and <a href=\"http://ghr.nlm.nih.gov/condition/pantothenate-kinase-associated-neurodegeneration\" target=_blank>pantothenate kinase-associated neurodegeneration</a> (PKAN).[4798]","dateModified":"2011-12-21T12:09:00"},"basicQuestions":[{"questionId":5804,"questionText":"How might neuroacanthocytosis be treated?","answerText":"There is currently no cure for neuroacanthocytosis. Management generally focuses on the specific symptoms that are present in each individual and may require the coordination of various specialists. Psychiatric symptoms and chorea may be treated with certain antipsychotic medications known as dopamine-receptor blocking drugs.&nbsp;Other antipsychotic medications as well as <a href=\"http://www.nlm.nih.gov/medlineplus/antidepressants.html\" target=_blank>antidepressants</a> and/or sedatives may also be used to treat some affected individuals. Seizures may be treated with anti-convulsants, which may also help to treat psychiatric symptoms. Anti-seizure medications that can can worsen involuntary movements are generally avoided. Dystonia has been treated with <a href=\"http://mdc.mbi.ufl.edu/dystonia/botulinum-toxin-injections-for-dystonia\" target=_blank>botulinum toxin</a> to relax the muscles and reduce spasms. Because of feeding difficulties in some cases, individuals may need to have their nutrition monitored. Nutritional support, supplementation and/or a feeding tube may be necessary in some cases. Additional therapies that may be used to treat affected individuals may include speech therapy, physical therapy and occupational therapy. Mechanical devices, such as braces or a wheelchair, may benefit some people. Computer-assisted speech devices may be necessary in some cases.[4798]<br><br>More detailed information about treatment for neuroacanthocytosis is available on eMedicine's Web site and can be viewed by clicking <a href=\"http://emedicine.medscape.com/article/1152923-treatment\" target=_blank>here</a>.","dateModified":"2011-12-28T14:41:00","resourceClassificationName":"Treatment","references":[{"referenceId":4798,"authors":"","articleTitle":"Neuroacanthocytosis","bookWebsiteJournalTitle":"NORD","date":"March 30, 2011","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/975/viewAbstract","dateAccessed":"2011-12-21T00:00:00"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":3956,"relatedDiseaseName":"Chorea-acanthocytosis","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":6564,"relatedDiseaseName":"Pantothenate kinase-associated neurodegeneration","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":33412,"abbreviatedInquiry":"I have 3 brothers (and one that died 3 years ago) suffering from a genetic rare disease,&nbsp;neuroacanthocytosis. I am looking for any information about new medicines or any other suggestions.","caseQuestions":[{"questionId":5804,"questionText":"How might neuroacanthocytosis be treated?","answerText":"There is currently no cure for neuroacanthocytosis. Management generally focuses on the specific symptoms that are present in each individual and may require the coordination of various specialists. Psychiatric symptoms and chorea may be treated with certain antipsychotic medications known as dopamine-receptor blocking drugs.&nbsp;Other antipsychotic medications as well as <a href=\"http://www.nlm.nih.gov/medlineplus/antidepressants.html\" target=_blank>antidepressants</a> and/or sedatives may also be used to treat some affected individuals. Seizures may be treated with anti-convulsants, which may also help to treat psychiatric symptoms. Anti-seizure medications that can can worsen involuntary movements are generally avoided. Dystonia has been treated with <a href=\"http://mdc.mbi.ufl.edu/dystonia/botulinum-toxin-injections-for-dystonia\" target=_blank>botulinum toxin</a> to relax the muscles and reduce spasms. Because of feeding difficulties in some cases, individuals may need to have their nutrition monitored. Nutritional support, supplementation and/or a feeding tube may be necessary in some cases. Additional therapies that may be used to treat affected individuals may include speech therapy, physical therapy and occupational therapy. Mechanical devices, such as braces or a wheelchair, may benefit some people. Computer-assisted speech devices may be necessary in some cases.[4798]<br><br>More detailed information about treatment for neuroacanthocytosis is available on eMedicine's Web site and can be viewed by clicking <a href=\"http://emedicine.medscape.com/article/1152923-treatment\" target=_blank>here</a>.","dateModified":"2011-12-28T14:41:00","resourceClassificationName":"Treatment","references":[{"referenceId":4798,"authors":"","articleTitle":"Neuroacanthocytosis","bookWebsiteJournalTitle":"NORD","date":"March 30, 2011","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/975/viewAbstract","dateAccessed":"2011-12-21T00:00:00"}]},{"questionId":5845,"questionText":"Where can I find the most up-to-date information about new treatments for neuroacanthocytosis?","answerText":"The U.S. National Institutes of Health, through the National Library of Medicine, developed <a href=\"http://www.clinicaltrials.gov/ct2/home\" target=_blank>ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies. To find trials regarding neuroacanthocytosis, click on the link above and use \"neuroacanthocytosis\" as your search term. Individuals may also search for specific symptoms or complications of the disorder by using the appropriate term in a search. Although there may not be any trials listed at a specific point in time, the site is updated regularly and may be checked often.<br><br>You&nbsp;can find relevant articles on neuroacanthocytosis through PubMed, a searchable database of biomedical journal articles. Although not all of the articles are available for free online, most articles listed in PubMed have a summary available. To obtain the full article, contact a medical/university library or your local library for interlibrary loan. You can also order articles online through the publisher’s Web site. Using \"neuroacanthocytosis\" as your search term should help you locate articles. Use the Advanced or Limits&nbsp;features to narrow your search results. <a href=\"http://www.ncbi.nlm.nih.gov/PubMed\" target=_blank>Click here</a> to view a search.<br><br>The National Library of Medicine (NLM) Web site has a page for locating libraries in your area that can provide direct access to these journals (print or online). The Web page also describes how you can get these articles through interlibrary loan and Loansome Doc (an NLM document-ordering service). You can access this page at the following link: <a href=\"http://nnlm.gov/members/\" target=_blank>http://nnlm.gov/members/</a>. You can also contact the NLM toll-free at 888-346-3656 to locate libraries in your area.","dateModified":"2011-12-28T13:55:00","resourceClassificationName":"Treatment","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Neuroacanthocytosis"}